BINGAMAN, David, P.,CHANEY, Paul, G.,WAX, Martin, B.
申请号：
HK16104118.1
公开号：
HK1216236A
申请日:
2016.04.11
申请国别(地区):
HK
年份:
2016
代理人:
摘要：
The present invention relates to topical formulations comprising a compound of the following formula:for treating ocular neovascularization. The Compound-I is present in a solution or a suspension in about 0.005% to about 5.0% w/v, such that the solution or suspension delivers the compound at the posterior segment of the eye for inhibiting VEGF in the retina and/or the choroid.
